Geftistar 250mg Tablet (Geftinib)
Price range: US$ 110 through US$ 662
| Active Ingredient | |
|---|---|
| Strength | 250mg |
| Dosage Form | Tablet |
| Manufacturer | |
| Packaging | 10 tablets in a strip |
| Delivery Time | 12-18 Working Days |
Description
Buy Geftistar Online, which is an anti-cancer medication used in the treatment of breast and lung cancers. Geftistar 250 mg is a cytotoxic chemotherapy agent that slows down the production of cancer cells, inhibiting the spread of the malignant tissues. Geftinib 250 mg should be used under the supervision of a qualified doctor. Geftinib Talets are not recommended for use in patients with lung and liver diseases.
How to Use Geftistar 250 mg?
Geftistar 250 mg comes as a tablet to take orally with or without food. The recommended daily dosage is one tablet a day. However, if the dose is missed, take the pill as soon as one remembers, but if it’s time for the later dose, skip the missed one. It is better to take the Geftinib 250 mg as recommended by the doctor.
Side Effects of Geftinib 250 mg
Geftistar 250 mg causes some side-effects like nausea, rashes, vomiting, loss of appetite, weakness, dry skin, inflammation of the mouth, and diarrhea. All these side effects are temporary that subsides within a day or two.
1 review for Geftistar 250mg Tablet (Geftinib)
Related products
-
Cellcept 500mg Tablet (Mycophenolate Mofetil)
Price range: US$ 107 through US$ 643 Select options This product has multiple variants. The options may be chosen on the product page -
Capnat 500mg Tablet (Capecitabine)
Price range: US$ 164 through US$ 986 Select options This product has multiple variants. The options may be chosen on the product page -
Calutide 50mg Tablet (Bicalutamide)
Price range: US$ 51 through US$ 307 Select options This product has multiple variants. The options may be chosen on the product page -
Cassotide 50mg Tablet (Bicalutamide)
Price range: US$ 52 through US$ 309 Select options This product has multiple variants. The options may be chosen on the product page
I was diagnosed with an inoperable NSCLC on March 11. I am using Iressa as first-line therapy. I had no reactions for about fourteen days, then the rash all over began.